| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/24/1998 | US5840873 Plurality of different oligonucleotide probes each coupled to different chemiluminescent label |
| 11/24/1998 | US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer |
| 11/24/1998 | US5840870 Polynucleotides PANC1A and PANC1B associated with pancreatic cancer |
| 11/24/1998 | US5840869 DNA encoding interleukin-4 receptors |
| 11/24/1998 | US5840868 Pesticidal proteins and strains |
| 11/24/1998 | US5840866 Human ubiquitin-conjugating enzyme |
| 11/24/1998 | US5840865 Dna sequences which hybridize under stringent conditions to minos-1 or code for transposase protein; tc-1 gene family; insertion of dna into cell |
| 11/24/1998 | US5840862 Process for aligning, adhering and stretching nucleic acid strands on a support surface by passage through a meniscus |
| 11/24/1998 | US5840857 Purification of post-menopausal urinary concentrate by immunochromatography and reverse phase high pressure liquid chromatography; biologically active product is free from lutenizing hormone and other proteins; fertility agents |
| 11/24/1998 | US5840854 Monoclonal antibody BR110 and uses thereof |
| 11/24/1998 | US5840853 Parathyroid hormone receptor and DNA encoding same |
| 11/24/1998 | US5840847 Purified prostaglandin receptor FP |
| 11/24/1998 | US5840846 Fibronectin binding protein as well as its preparation |
| 11/24/1998 | US5840845 Senescent cell derived inhibitors of DNA synthesis |
| 11/24/1998 | US5840843 Synthetic polypeptides as inhibitors of HIV-1 |
| 11/24/1998 | US5840842 Receptor-type phosphotyrosine phosphatase-sigma |
| 11/24/1998 | US5840840 Selective RNase cytotoxic reagents |
| 11/24/1998 | US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 11/24/1998 | US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product |
| 11/24/1998 | US5840710 Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| 11/24/1998 | US5840708 Administering antisense oligonucleotide which hybridizes to expression controlling sequence of nucleic acid encoding dopamine receptor to inhibit production |
| 11/24/1998 | US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component |
| 11/24/1998 | US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 11/24/1998 | US5840693 Vascular endothelial growth factor-B |
| 11/24/1998 | US5840687 Polypeptides for kinases |
| 11/24/1998 | US5840679 Method of inhibiting P-selectin ligand activity |
| 11/24/1998 | US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors |
| 11/24/1998 | US5840578 Methods for determining susceptibility to lead poisoning |
| 11/24/1998 | US5840577 Animal 2-5A-dependent RNases and encoding sequences therefor |
| 11/24/1998 | US5840576 Methods and compositions of growth control for cells encapsulated within bioartificial organs |
| 11/24/1998 | US5840574 Nucleotide sequence including coding portion of marek*s disease virus gene |
| 11/24/1998 | US5840570 Aspartic proteinase deficient filamentous fungi |
| 11/24/1998 | US5840569 Human GTP-binding proteins |
| 11/24/1998 | US5840568 Screening for hodgkin's disease using a nucleic acid molecule which encodes a hodgkin's disease specific antigen |
| 11/24/1998 | US5840566 Isolation of a gene encoding human thyrotropin beta subunit |
| 11/24/1998 | US5840565 Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
| 11/24/1998 | US5840564 Variant having amino acid substitutions or deletions and at least a protease domain and n-terminal region associated with fibrin binding; drugs for vascular disorders |
| 11/24/1998 | US5840561 Phytase |
| 11/24/1998 | US5840560 Glucose kinase from streptococcus pneumoniae |
| 11/24/1998 | US5840559 Isolated and purified polynucleotide sequence coding polypeptide; hybridization probes; vectors and host cells for gene expression; anticancer and antitumor agents |
| 11/24/1998 | US5840558 Soybean peroxidase gene family and an assay for detecting soybean peroxidase activity |
| 11/24/1998 | US5840557 Method for producing seeds and plants thereof involving an in vitro step |
| 11/24/1998 | US5840556 Molecular genetic construction of vaccine strains of pasteurellaceae |
| 11/24/1998 | US5840555 Transcriptional regulatory regions derived from the K18 gene |
| 11/24/1998 | US5840554 β-Endotoxin expression in pseudomonas fluorescens |
| 11/24/1998 | US5840550 Splits d-glucosyl linkage in xyloglucan molecule, links this reducing end to non-reducing end of d-glucose of other xyloglucan molecule; control of plant morphology e.g. crosslinking of cellulose in plant cell wall |
| 11/24/1998 | US5840549 Male infertility Y-deletion detection battery |
| 11/24/1998 | US5840545 Immunoglubulins |
| 11/24/1998 | US5840544 DNA encoding rantes homolog from prostate |
| 11/24/1998 | US5840543 Fermentation process |
| 11/24/1998 | US5840542 Method for manufacture of proinsulin with high export yield |
| 11/24/1998 | US5840541 Recombinant molecule comprising the polyhedrin gene promoter of baculovirus and a structural gene of a rotovirus; biosynthesis of antigenic protein ns28; use in vaccines, viral detection |
| 11/24/1998 | US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein |
| 11/24/1998 | US5840539 Polynucleotides encoding a vesicle transport associated proteins |
| 11/24/1998 | US5840538 Lgt |
| 11/24/1998 | US5840535 DNA encoding a zinc ring protein |
| 11/24/1998 | US5840534 Pure polynucleotide encoding an amino acid sequence; culturing cell containing expression vector; gene family important in cell division; preventing genetic defects |
| 11/24/1998 | US5840533 Tissue plasminogen activator |
| 11/24/1998 | US5840532 Recombinant nucleic acid |
| 11/24/1998 | US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs |
| 11/24/1998 | US5840530 DNA encoding receptors for the beta-2 chain of human IL-12 |
| 11/24/1998 | US5840529 Mammalian pro-hormone convertase |
| 11/24/1998 | US5840528 Overexpression of carotenoids in protoplasts using recombinant dna comprising precursor gene with detectable marker operably linked to regulatory sequences; stability |
| 11/24/1998 | US5840527 Lung surfactant proteins |
| 11/24/1998 | US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis |
| 11/24/1998 | US5840525 P185 receptor implicated in cellular growth |
| 11/24/1998 | US5840524 Antiinflammatory agents is the culture product from genetic engineered cell; receptor binding activity |
| 11/24/1998 | US5840523 Using translation initiation region variant (including signal sequence of stii, ompa, phoe, lamb, mbp, and phoa) operably linked to unaltered amino acid coding region; variant has reduced translational strength but increased secretion |
| 11/24/1998 | US5840522 Recombinant lectins |
| 11/24/1998 | US5840521 Teta and tetr genes induced by tetracycline and repressed in its absence, expressing a heterologous protein such as ricin a; no penicillin selection markers; highly stable vectors; product of selection only expressed in testing phase |
| 11/24/1998 | US5840520 Recombinant negative strand RNA virus expression systems |
| 11/24/1998 | US5840518 Biosynthetic fusion protein comprising a polypeptide segment with a specified amino acid sequence giving signal, promoting transformed cell to secrete fusion protein |
| 11/24/1998 | US5840517 Process for preparing obesity protein analogs |
| 11/24/1998 | US5840513 Antibodies directed to pagC peptides for the detection of salmonellae |
| 11/24/1998 | US5840511 Methods comprising calcium independent cytosolic phospholipase A/B enzymes |
| 11/24/1998 | US5840505 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
| 11/24/1998 | US5840498 Antibiotic cryptdin peptides and methods of their use |
| 11/24/1998 | US5840497 Single stranded oligonucleotide containing 5-methyl deoxycytosine hybridizes during s phase to promoter containing cpg doublets causing inheritable deactivation; reversed by demethylating agent |
| 11/24/1998 | US5840496 Method for diagnosing endometrial cancer |
| 11/24/1998 | US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity |
| 11/24/1998 | US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy |
| 11/24/1998 | US5840491 DNA sequence encoding the Machado-Joseph disease gene and uses thereof |
| 11/24/1998 | US5840489 Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome |
| 11/24/1998 | US5840483 Method of maintaining a desired recombinant gene in a genetic population of cells |
| 11/24/1998 | US5840481 Transforming host cells with expression vector; gene product disrupts an essential activity of virus |
| 11/24/1998 | US5840480 Retrovirus from the HIV group and its use |
| 11/24/1998 | US5840479 Synthetic human antibody-dna comprising an expression vector with inserted random sequences for the antibody hypervariable regions; clones able secrete specific antibodies or antigen-binding domain |
| 11/24/1998 | US5840344 Monoclonal antibodies having property of causing apoptosis |
| 11/24/1998 | US5840316 Desensitization |
| 11/24/1998 | US5840315 Treating or preventing bovine mastitis |
| 11/24/1998 | US5840314 Production of streptococcal M protein |
| 11/24/1998 | US5840312 Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein |
| 11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
| 11/24/1998 | US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
| 11/24/1998 | US5840299 Binding and treatment of multiple sclerosis |
| 11/24/1998 | US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 11/24/1998 | US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
| 11/24/1998 | US5840296 Engineered cytotoxic ribonuclease A |
| 11/24/1998 | US5839224 Aromatic aldehydes as insecticides and for killing arachnids |
| 11/24/1998 | CA2077921C Bioprocess for preparing 7-adca |